Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H (3378) Press Release
Next Day Disclosure Return
Earlier from Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H
- Voluntary announcement notice on voluntary extension of lock-up period by shareholders
- Voluntary announcement inclusion of Hanx Biopharmaceuticals in the ftse global micro cap index